NCT03816462Completed
ReNEW Clinic Cohort Study
Reversing the Negative Cardiovascular Effects of Weight (ReNEW) Clinic Cohort Study
Source: ClinicalTrials.gov · Last updated 20 Jan 2026
Brief summary (registry, in English)
This is an ongoing, prospective cohort study of children and young adults who are evaluated in the Reversing the Negative Effects of Weight on the Heart (ReNEW) Clinic at Johns Hopkins University. Demographic and clinical data of patients who agree to participate are obtained via chart review and entered into a longitudinal clinic registry.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 22 Jan 2019
- Start date
- Jan 2015
- Primary completion date
- Jan 2026
- Lead sponsor
- Johns Hopkins University
- Diseases
- Obesity, High blood pressure
- NCT number
- NCT03816462
What you commit to
- Study type: Observational
- Planned participants: 200
- From Jan 2015 to the primary completion date, Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Children who are wards of the state or who are non-English speaking without an in-person interpreter accompanying them to the clinic visit.
Who the study is looking for
- Children and young adults with overweight or obesity referred for evaluation of elevated blood pressure in the ReNEW Clinic at Johns Hopkins University are eligible.
Age in the registry: - to 22 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.